Long-term pulmonary consequences of respiratory distress syndrome in preterm infants treated with exogenous surfactant-Reference-Cited by-同舟云学术

Long-term pulmonary consequences of respiratory distress syndrome in preterm infants treated with exogenous surfactant

Published:1993-03 Issue:3 Volume:122 Page:446-452
ISSN:0022-3476
Container-title:The Journal of Pediatrics
language:en
Short-container-title:The Journal of Pediatrics

Author:

Abbasi Soraya,Bhutani Vinod K.,Gerdes Jeffrey S.

Publisher

Elsevier BV

Subject

Pediatrics, Perinatology and Child Health

Reference31 articles.

1. Double-blind clinical trial of calf lung surfactant extract for the prevention of hyaline membrane disease in extremely premature infants;Kwong;Pediatrics,1985

2. Prophylactic treatment of very premature infants with human surfactant;Merritt;N Engl J Med,1986

3. Double-blind controlled trial of single dose treatment with bovine surfactant in severe hyaline membrane disease;Raju;Lancet,1987

4. A multicenter randomized, placebo-controlled trial of surfactant therapy for respiratory distress syndrome;Horbar;N Engl J Med,1989

5. A controlled trial of human surfactant replacement therapy for severe respiratory distress syndrome in very low birth weight infants;Lang;J Pediatr,1990

Cited by 34 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pulmonary surfactant and COVID-19: A new synthesis;QRB Discovery;2022

2. Exogenous surfactant therapy;Goldsmith's Assisted Ventilation of the Neonate;2022

3. How best to capture the respiratory consequences of prematurity?;European Respiratory Review;2018-03-14

4. Pharmacologic Therapies I;Assisted Ventilation of the Neonate;2017

5. Surfactant;Pediatric and Neonatal Mechanical Ventilation;2014-04-10